Sanofi's Sarclisa cuts death risk in mutiple myeloma

12th May 2020 Uncategorised 0

The Phase III IKEMA trial hit its primary endpoint

More: Sanofi's Sarclisa cuts death risk in mutiple myeloma
Source: News